ITOS
Iteos Therapeutics, Inc.
Director Aaron I. Davis sold $13.9M of Iteos Therapeutics, Inc.
Sold$13,949,234
$21.04Price
663,000Shares
−24%Stake
What ITOS did after the filing
- The stock from Thu, May 12 open, $17.29
- +21.3%
- S&P 500, same days
- +0.2%
Measured over 30 trading days, to the Jun 27 close.
Traded Mon, May 9. Filed Wed, May 11, 5:15 PM ET, after the close. Returns use the May 12 open and the Jun 27 close. Not investment advice.